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ABSTRACT
Escherichia coli possesses only one essential oli-
goribonuclease (Orn), an enzyme that can degrade
oligoribonucleotides of five residues and shorter in
length (nanoRNA). Firmicutes including Bacillus
subtilis do not have an Orn homolog. We had pre-
viously identified YtqI (NrnA) as functional analog
of Orn in B. subtilis. Screening a genomic library
from B. subtilis for genes that can complement a
conditional orn mutant, we identify here YngD
(NrnB) as a second nanoRNase in B. subtilis. Like
NrnA, NrnB is a member of the DHH/DHHA1 protein
family of phosphoesterases. NrnB degrades
nanoRNA 5-mers in vitro similarily to Orn. Low
expression levels of NrnB are sufficient for orn com-
plementation. YhaM, a known RNase present in
B. subtilis, degrades nanoRNA efficiently in vitro
but requires high levels of expression for only partial
complementation of the orn
– strain. A triple mutant
(nrnA
–, nrnB
–, yhaM
–)i nB. subtilis is viable and
shows almost no impairment in growth. Lastly,
RNase J1 seems also to have some 5’-to-3’ exoribo-
nuclease activity on nanoRNA and thus can poten-
tially finish degradation of RNA. We conclude that,
unlike in E. coli, degradation of nanoRNA is per-
formed in a redundant fashion in B. subtilis.
INTRODUCTION
RNA turnover is an essential process associated with
the regulation of gene expression in all organisms.
Gram-positive and Gram-negative bacteria employ diﬀer-
ent principal mechanisms of RNA degradation and are
equipped with diﬀerent sets of ribonucleases. This can be
exempliﬁed by the fact that two essential RNases in the
model bacterium E. coli, RNase E and oligoribonuclease
(Orn), are absent in Bacillus subtilis.I nE. coli, RNase E
often initiates the degradation of mRNA endonucleolyti-
cally, which is followed by exonucleolytic degradation in
a3 0 to 50 direction catalyzed by several other enzymes (1).
These exonucleases are unable to complete the degrada-
tion of RNA due to their inability to degrade RNA in the
size range of 2–5nt. For example, the end products of
degradation catalyzed by RNase II and RNase R were
found to be 3- to 5-mers (2) or 4- to 6-mers (3,4) and 2-
to 3-mers (2,5) or 1- to 2-mers (4), respectively.
We had recently introduced the term ‘nanoRNA’ in
order to distinguish these extremely short oligonucleotides
from the longer microRNAs (6). We had chosen the term
nano in reference to its roots: Nano originates from the
Greek word nanos, which means dwarf. Micro on the
other hand descends from the Greek word mikros, which
means small. Nano is therefore used in this context simply
to articulate ‘smaller than’ micro.
The fact that most exonucleases present in E. coli
cannot complete the degradation of RNA gives impor-
tance to the only exoribonuclease capable of degrading
nanoRNA: Orn (7–9).
In B. subtilis, the situation is less well understood. Here,
RNase J1, an essential enzyme with no E. coli homolog,
was originally identiﬁed as an endonuclease functionally
analogous to E. coli RNase E, but was later shown to also
have 50–30 exonuclease activity (10).
In a previous attempt to ﬁnd a functional analog of Orn
in B. subtilis, we had identiﬁed YtqI (NrnA) as an enzyme
that has nanoRNase activity in vitro and can complement
an E. coli orn mutant when expressed at low levels (6).
This identiﬁcation was done through the binding of
NrnA to 30-phosphoadenosine 50-phosphate (pAp),
exploiting the conserved strong interaction between pAp
and oligoribonucleases, which was shown for Orn (E. coli)
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nanoRNase activity, NrnA has pAp-phosphatase activity,
as demonstrated by the ability to complement a mutation
in the E. coli gene coding for pAp-phosphatase, cysQ and
to degrade pAp to AMP in vitro. Consistent with this
second activity of NrnA, the phenotype of a ytqI (nrnA)
mutant in B. subtilis resembles that of an E. coli cysQ
mutant, namely its growth in the absence of cysteine is
impaired. The non-essentiality of nrnA implied the exis-
tence of at least one more enzyme with an ability to
degrade nanoRNA. Here we demonstrate that, unlike in
E. coli, enzymes with nanoRNase activity are redundantly
present in B. subtilis; in particular, we identify a protein of
previously unknown function, YngD (now named NrnB),
as a nanoRNase and we test the activity of YhaM and
RNase J1 on nanoRNA.
MATERIALS AND METHODS
Strains, plasmids and growth conditions
Strains, plasmid and primers used in this study are listed in
Table 1.
E. coli and B. subtilis strains were grown in LB.
Arabinose was present for induction of the Para promoter
as indicated. Ampicillin (100mg/ml), kanamycin (5–10mg/
ml), erythromycin (1mg/ml) together with lincomycin
(25mg/ml), phleomycin (1mg/ml), chloramphenicol (5mg/
ml) was added for plasmid maintenance or to select for
chromosomal markers. Anhydrotetracycline (Atc) was
added at 250ng/ml for induction of PLtetO-1.
The plasmids for the expression of his-tagged YhaM
and NrnB (pUM413 and pUM414, respectively) were
constructed as follows: primer UM177 plus UM178 and
UM179 plus UM180 were used to amplify yhaM or yngD
(nrnB), respectively from B. subtilis 168 chromosomal
DNA. The EcoRI, XhoI digested fragments were used
to replace the CDS from pUM407 leaving the region
coding for the C-terminal his-tag and the ribosomal bind-
ing site intact. pUM416 expressing yhaM under control of
PLac in pUC18 was constructed by PCR-amplifying yhaM
including the region coding for the his-tag from pUM413
using primer UM191 and UM193 and inserting the
EcoRI/XbaI digested fragment into pUC18 digested
with EcoRI and XbaI.
pFM1 was generated by PCR amplifying yhaM includ-
ing its own promoter from the chromosome of B. subtilis
168 and direct TA-cloning. This method exploits the ter-
minal transferase activity of Taq polymerases that adds a
30-A overhang to each end of the PCR products for clon-
ing into a vector with 30-T overhangs [pGEMT-Easy
(Promega)]. Clones carrying an insert were sequenced
using primers UM172 and UM173.
For the construction of pUM443 expressing his-tagged
NrnB-DHH mutant protein with alanine replacements of
amino acids D86, H87 and H88, two PCR fragments were
ampliﬁed using pUM414 as template: PCR1 was per-
formed with primers UM238 and UM240, and PCR2
was performed with primers UM179 and UM239. The
outside primers UM179 and UM240 and equimolar
amounts of PCR fragments 1 and 2 were used to perform
overlapping PCR. The obtained PCR fragment was
digested with EcoRI and SacI, and was used to replace
the EcoRI/SacI fragment of pUM414. The obtained clone
was veriﬁed by sequence analysis.
pDG148-rnjA was constructed by PCR-amplifying the
rnjA gene from the chromosome of B. subtilis 168 using
oligos RD1 and RD2. The obtained PCR fragment was
cleaved with HindIII and XbaI and cloned into pDG148
(12) digested with HindIII and XbaI.
The B. subtilis nrnB mutant (UM545) was created by
replacing nrnB with a cassette coding for chloramphenicol
acetyl transferase (cat). To this end, three PCR fragments
were generated: PCR1 and 2 ampliﬁed the 730-nt
upstream and 539-nt downstream regions of nrnB using
primers UM183 plus UM184 and UM185 plus UM186,
respectively from B. subtilis 168 chromosomal DNA.
PCR3 ampliﬁed the cat-cassette from pMK4 using prim-
ers IV211bis and MF80. Equimolar amounts of PCR1, 2
and 3 and the outside primers UM183 and UM186 were
used for overlapping PCR. The obtained PCR fragment
was cloned by TA-cloning into pGEMT-Easy. Plasmid
DNA of a sequence-veriﬁed clone (pUM420) was linear-
ized by ScaI and used to transform B. subtilis. Correct
integration of the cat-cassette was veriﬁed on chromo-
somal DNA of chloramphenicol-resistant clones using
primers UM187 plus UM188 and UM189 plus UM190
amplifying a 1286 or 1358nt long PCR fragment for the
50 or 30 site of integration, respectively.
The nrnA::Em
R mutant (BFS66) was part of the
European/Japanese eﬀort to inactivate the complete gene
set of B. subtilis 168 and has an insertion after amino acid
108 (13). In order to create an nrnA::Km
R allele (UM599),
pEC23 was linearized by ScaI and transformed into the
nrnA::Em
R mutant. Erythromycin-sensitive/kanamycin-
resistant clones were veriﬁed by PCR using primers
UM196 plus UM211 and UM209 plus UM210. The
yhaM::Phleo
R allele (14) was obtained from David
Bechhofer [strain BG395 (15)] and transformed into
B. subtilis 168 selecting for phleomycin resistant/chloram-
phenicol sensitive clones to create UM517. For the
construction of UM579 carrying nrnA under control of
PSpac, pUM432 was transformed into B. subtilis 168.
Erythromycin-resistant clones were veriﬁed by PCR
using primers UM196 plus UM211 and UM209 plus
UM210. pUM432 was generated as follows: a PCR frag-
ment containing nt 1–328 plus 23-nt upstream of the ATG
start codon was ampliﬁed from chromosomal DNA of
B. subtilis 168 using primers UM196 and UM197, digested
with HindIII and BamHI and cloned into pMUTIN4 cut
with HindIII and BamHI.
The B. subtilis mutants containing multiple mutant
alleles were created by transforming chromosomal DNA
of the donor to the recipient strains. Mutant alleles in the
recipient strains were veriﬁed by PCR analysis conﬁrming
both the 50 and 30 site of integration using the above-
mentioned primers that were used to conﬁrm correct inte-
gration of the original nrnA-o rnrnB-mutant alleles.
The yhaM mutant allele was conﬁrmed by PCR using
primers UM177 and UM178. The order of combining
the mutant alleles to create the triple mutant was as
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Description Reference
Strains
MG1655 E. coli K12 wild type Ref.
B. subtilis 168 B. subtilis 168 wild type Ref.
CF10230 nic+ derivative of DY329 (29) M. Cashel, unpublished
results
UM285 As CF10230 but cysQ,K m
R (11)
UM341 As CF10230 but orn under control of P LtetO-1, TetR, Km
R (6)
UM517 B. subtilis 168, yhaM::Phleo
R This study
UM545 B. subtilis 168, nrnB::Cm
R This study
UM579 B. subtilis 168, PSpac::nrnA This study
UM599 B. subtilis 168, nrnA::Km
R This study
UM612 B. subtilis 168, PSpac::nrnA, nrnB::Cm
R This study
UM623 B. subtilis 168, PSpac::nrnA, nrnB::Cm
R, yhaM::phleo
R This study
UM629 UM623 carrying pMAP65 This study
UM638 B. subtilis, nrnB::Cm
R, nrnA::Km
R This study
UM645 B. subtilis 168, nrnB::Cm
R, yhaM::Phleo
R This study
UM647 B. subtilis 168, nrnB::Cm
R, yhaM::Phleo
R, nrnA::Km
R This study
UM651 B. subtilis 168, nrnB::Cm
R, yhaM::Phleo
R, nrnA::Em
R This study
BFS66 B. subtilis 168, nrnA::pMUTIN2MCS, Em
R (13)
Plasmids
pBAD18 Vector, Para, pBR replicon, Ap
R (30)
pBSL10 Genomic library clone containing nt 1 068 397–1 070 326 of the B. subtilis genome in pCDNA 2.1 This study
pGEM-T Easy Vector for TA cloning Promega
pMAP65 Vector containing lacI (31)
pMutin4 Vector for gene inactivation in B. subtilis (32)
pEC23 pMutin derivative for replacement of EmR by KmR M. Simon and P. Stragier,
unpublished results
pUM404 As pBAD18, CysQ with C-terminal his-tag (11)
pUM408 As pBAD18, Orn with C-terminal his-tag (11)
pUM413 As pBAD18, YhaM with C-terminal his-tag This study
pUM414 As pBAD18, NrnB with C-terminal his-tag This study
pUM416 As pUC18, YhaM with C-terminal his-tag under control of PLac This study
pUM420 pGEMT-Easy carrying a fragment allowing construction of the nrnB::Cm
R replacement allele This study
pUM432 nrnA (nt 1–327) under control of PSpac in pMUTIN4 This study
pUM443 As pBAD18, NrnB (D87A, H88A, H89A) with C-terminal his-tag This study
pFM1 YhaM in pGEMT-Easy under control of its native promoter and in opposite direction to PLac This study
pMK4 shuttle vector, source for cat-cassette (33) and Genbank
EU549778
pDG148-rnjA pDG148 carrying rnjA coding for RNase J1 under control of PSpac This study
Primers
FM1 50GGGGAATTCTAAAAAGAGGTTCTATAGCTGAAAATCGC30
IV211bis 50GTACAGTCGGCATTATCTCAT30
MF80 50CGGCAATAGTTACCCTTATTAT30
UM172 50GTGCTGCAAGGCGATTAAGT30
UM173 50CGCCAAGCTATTTAGGTGAC30
UM179 50GGGGAATTCACCATGTATCATTTATATTCACATAACGACTTGGA30
UM180 50GGGGCTCGAGCTTGCGATGTTGATTTGCCAGCTTCAGATT
CTCCGCTAAAAATGCGACAAACACTTCATCCC30
UM183 50AGGAGGCGTCTTATTCCACGATTC30
UM184 50CTTATCTTGATAATAAGGGTAACTATTGCCGATGTAGGCCCCTTTTTATGA
TAAACTGAC30
UM185 50GGCTTTTATAATATGAGATAATGCCGACTGTACAAAAATATGCATAGGG
GAGCGTCAG30
UM186 50CTTATGGCGGCTATATGGTATCGG30
UM187 50ACAGCCTGTCGGCATTGTTG30
UM188 50CTAACTCTCCGTCGCTATTG30
UM189 50CAATAGCGACGGAGAGTTAGG30
UM190 50TTGCCGTAAGGAGCCGATCCA30
UM196 50GCCGAAGCTTTAAAAACAATAAAGGAGTATCAA30
UM197 50CGCGGATCCTGGATCTTCGTTCGGATGGT30
UM198 50GGGGCATGCTTATTTATGAAATGTCGGTTTATAAAAGG30
UM209 50CAGCTTCCAGCCGTGCTCTT30
UM210 50TGCCTACCTAGCTTCCAAGA30
UM211 50GTGCTGCAAGGCGATTAAGT30
UM238 50GTGAAGCTCATTGCGGCCGCGAAAACAGCCCTTCATTTGAATG30
UM239 50GAAGGGCTGTTTTCGCGGCCGCAATGAGCTTCACTTTGCCCCCTGCA30
UM240 50GGGGAGCTCTGTGAATTGATCTAAGGCGTTTG30
RD1 50TATTAAGCTTGTATTGGAGTTATGAGCGGTATGAAATTTG30
RD2 50TATATCTAGAGTAAAATCATTTCAACACATATCACTGC30
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R,2 .yhaM::Phleo
R,3 .nrnA::Km
R or
nrnA::Em
R.
The genomic library of B. subtilis 168 was kindly sup-
plied by Florence Hommais and was prepared as
described hereafter: genomic DNA was fragmented by
nebulization. Fragments of  2-kb length were puriﬁed
from an agarose gel and integrated into the BstXI site of
pCDNA 2.1 using linkers.
Purification of his-tagged proteins and activity assays
Puriﬁcation of C-terminally his-tagged NrnB protein from
E. coli carrying pUM414 seemed to be diﬃcult due to
problems of solubility. We therefore tested several buﬀers
and salts and found that surprisingly, NrnB seemed to be
most soluble in water. As nickel-agarose puriﬁcation
cannot be performed in water, we decided to take advan-
tage of this unique property to purify NrnB. Resuspension
of the in 50mM KPi pH 8.0, 300mM NaCl insoluble
fraction in water solubilized mainly NrnB. The two
major contaminants were identiﬁed by mass-spectrometry
to be membrane proteins OmpA and OmpC, and could
therefore be removed by high-speed centrifugation
(45000rpm, 30min). The puriﬁed enzyme was estimated
to be >95% pure and was stable for several months when
kept on ice. The NrnB-DHH mutant protein was puriﬁed
according to an identical protocol from E. coli carrying
pUM443.
C-terminally his-tagged YhaM was puriﬁed from 1l
cultures of MG1655 carrying pUM413 grown at 308C.
Expression was induced at an OD600 of 0.5 by 0.2% ara-
binose for 3.5h. Subsequent puriﬁcation was according
to the protocol described before (11). Puriﬁed YhaM
was estimated to be  90% pure. YhaM was less stable
than other puriﬁed enzymes and lost activity over time.
Experiments comparing activity on RNA and DNA sub-
strates were therefore always performed simultaneously.
C-terminally his-tagged wild-type RNAse J1 and RNase
J1 (H46A) mutant protein were puriﬁed as described
before (10).
Activity assays on nanoRNA were performed on
custom-made RNA oligos essentially as described before
(6), but taking into account the buﬀer conditions that were
found to be optimal for NrnB activity: 50mM Tris pH 8.0,
5mM MnCl2. YhaM activity assays were performed in
5mM MnCl2, 50mM Tris pH 8.0, 100mM KCl. RNase
J1 activity was tested in 50mM Tris pH 8.0, 8mM MgCl2,
100mM NH4Cl, and 0.1mM DTT.
Assays determining degradation activity of NrnB on
longer substrate were done using a custom made RNA
24-mer (50CACACACACACACACACACACACA30)
50-end labeled with [g-
33P]ATP. This oligonucleotide was
labeled using the MirVana Probe and Marker Kit
(Ambion) in a 90ml reaction containing 450pmol oligo,
20pmol [g-
33P]ATP (35mCi), 180pmol ATP and 4.5ml
T4 Polynucleotide Kinase, incubated for one hour at
378C. The reaction was stopped by the addition of
10ml of 10mM EDTA and incubation at 958C for two
minutes. The reaction mixture was puriﬁed from the
unincorporated nucleotides using NucAway spin columns
(Ambion) according to the supplier’s instructions.
Concentration of labeled substrate was estimated to be
1.76 pmol/ml by measuring A260. Quantities of 5, 10 or
20ml of substrate were used in 40ml reactions containing
0.5 or 1mg NrnB or 5mg NrnB-DHH under the same
buﬀer and salt conditions used in activity assays on
nanoRNA. Reactions were started by adding enzyme
after 5min preincubation at 378C. Six-microliter aliquots
were taken at times indicated and added to an equal
volume of loading buﬀer and set on ice in order to stop
the reaction. After 3min at 958C, 7ml of the samples were
resolved on a 20% PAA, 7M Urea gel containing 2XTBE
that was run in 2XTBE. Labeling of the Decade-marker
was performed as described previously (6).
Expression of his-tagged proteins was monitored by
PAA gel electrophoresis, followed by staining with
BioSafe Coomassie stain (BIO-RAD) or by western blot
using Anti-His6 peroxidase antibodies (Roche) as des-
cribed before (6).
Phylogenetic analysis
NrnB orthologs were deﬁned by limiting the results of
an NCBI Blast search according to the following criteria:
 20% diﬀerence in protein length, alignment extends
over  80% of the protein, and  40% amino acid similar-
ity. Phylogenetic trees were constructed on http://
www.phylogeny.fr.
RESULTS
Identification of NrnB as potential nanoRNase
The viability of an nrnA mutant in B. subtilis 168 pointed
to the possible existence of a second enzyme that is capa-
ble of degrading nanoRNA in this organism. To search
for another potential nanoRNase we used a genomic
library of B. subtilis to screen for genes that complement
a conditional promoter mutant of E. coli oligoribonu-
clease (orn) (strain UM341). In this strain, orn is under
control of the anhydrotetracycline (Atc)-inducible pro-
moter PLtetO-1. Transformation of this strain with a
vector control (pBAD18) in the absence of Atc produced
pinpoint-sized colonies that stopped growing, whereas
transformants with a plasmid expressing orn (pUM408)
continued to grow and formed normal size colonies com-
pared to growth in the presence of Atc (Figure 1). Among
the clones allowing complementation of the orn
– strain
was a plasmid with a fragment spanning nt 1947002–
1948086 of the B. subtilis genome, containing one com-
plete CDS (from nt 1947525–1948721) namely yngD
(now nrnB). The function of YngD was unknown, but
like NrnA, it belongs to the DHH/DHHA1 protein
family (16) and was therefore a good candidate for a
nanoRNase. Homology between NrnA and NrnB does
not extend over the full-length protein and is restricted
instead to small areas containing the conserved motifs
characteristic for the protein family.
NrnB has nanoRNase activity in vivo
To conﬁrm that it was the expression of NrnB that
allowed complementation of E. coli orn
– from the genomic
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arabinose-inducible Para promoter in pBAD18. As seen in
Figure 1, expression of nrnB from pUM414 completely
rescued the growth defect of the E. coli orn mutant.
Here, expression was induced by the addition of
0.2% arabinose. Figure 1 shows that the colony sizes of
NrnB-expressing transformants in the absence of Atc (orn
–
background) are similar to those expressing Orn.
Complementation could be seen even in the absence of
arabinose (data not shown). Under these conditions we
could not detect NrnB either on a Coomassie-stained pro-
tein gel or by western blotting using Anti-His6 antibodies
(data not shown) suggesting that low levels of NrnB are
suﬃcient for orn
– complementation. The NrnB protein
expressed from pUM414 was C-terminally his-tagged.
As this protein allowed orn
– complementation, we con-
clude that the C-terminal his-tag does not interfere with
nanoRNase activity of NrnB.
NrnB activity on nanoRNA in vitro
Recombinant NrnB was puriﬁed to near homogeneity by
taking advantage of its unique solubility in water (see
‘Materials and Methods’ section).
NanoRNase activity was tested on nanoRNA 5-mers
(50Cy5-CCCCC30) and was easily detected in the presence
of manganese (Figure 2A and C). Manganese could be
replaced by cobalt with almost similar activity and with
magnesium with considerably lower, but still appreciable
activity (data not shown). NrnB was more active at pH 8.0
and pH 7.5 than at pH 7.0, and in Tris compared to
HEPES (data not shown). Therefore, subsequent experi-
ments were performed in Tris pH 8.0 in the presence
of manganese. The sequential appearance of reaction
products (Figure 2A) resembled Orn-catalyzed reactions
(6) and pointed to a similar reaction mechanism. Under
the conditions tested, the activity of NrnB measured as the
disappearance of substrate 5-mer can be estimated to be 1
nmol/min/mg.
We also tested the activity of NrnB on RNA oligos
diﬀerent from 50Cy5-CCCCC30, namely 50Cy5-AAAAA
30 (Figure 2B and D), 50Cy5-CCC30 (Figure 2E) and
50Cy5-AAA30 (Figure 2F). The degradation patterns
observed in NrnB-catalyzed degradations of 5-mers
50Cy5-CCCCC30 and 50Cy5-AAAAA30 were slightly dif-
ferent but did not suggest any strong preference for sub-
strates shorter than 5nt, as we had seen in the case
of NrnA (6). In agreement with this, the levels of NrnB
activity on 5-mers and 3-mers varied only within one order
of magnitude (Figure 2G). NrnB was somewhat (1.4-fold)
more active on 5-mer A’s than on 5-mer C’s. In contrast to
NrnA, NrnB was less active on 3-mers than on 5-mers
with a larger diﬀerence for the oligos containing A’s as
compared to the oligos containing C’s (0.5-fold versus
0.2-fold, respectively). This might explain why 3-mer inter-
mediates accumulate to a larger extent in reactions con-
taining 5-mer C’s as compared to 5-mer A’s (Figure 2C
and D).
In addition to its activity on nanoRNA, NrnA is able
to degrade pAp (6). We therefore asked whether NrnB
could also degrade pAp. NrnB was unable to complement
an E. coli cysQ mutant (UM285), however, when
expressed from pUM414 in the presence of 0.2% arabi-
nose (data not shown), precluding this possibility. NrnB
activity was also tested on DNA 5-mers (50Cy5-CCCCC30)
under identical conditions. NrnB could degrade DNA
5-mers with an activity of a similar order of magnitude
(0.7nmol/min/mg) (data not shown).
Activity of NrnB on a RNA 24-mer
We next asked whether NrnB speciﬁcally degraded
nanoRNA or whether it could also degrade longer sub-
strates as well, by testing its activity on a 24-mer (50CAC
ACACACACACACACACACACA30) that was 50-labeled
with
33P. Initial experiments showed some activity of NrnB
on the RNA 24-mer. As this activity could potentially arise
from impurities in the protein preparation, we constructed
a mutant enzyme to determine whether or not activity on
the 24-mer was inherent to NrnB. We chose to mutagenise
one of the motifs characteristic of the DHH protein family,
namelymotifIIIincludingAsp86,His87, His88.According
to structural and mutational analyses of other members of
the DHH protein family [RecJ from E. coli (17,18), PPX1
from Saccharomyces cerevisiae (19), and human Prune
(20)], this motif is important for activity, as it contributes
to the catalytic center. Amino acids Asp86, His87 and
His88 were replaced by alanine. We will refer to this
mutant from here on as the DHH mutant or NrnB-
DHH. To conﬁrm that this replacement aﬀected NrnB
activity, we ﬁrst tested its ability to complement E. coli
orn
–. As expected, this mutant was unable to rescue the
eﬀects of Orn deﬁciency (Figure 1). Next we puriﬁed
both wild-type NrnB and NrnB-DHH according to an
identical protocol. An activity of the DHH mutant protein
nrnB-DHH nrnB
orn
vector
Figure 1. Complementation of the conditional orn mutant by expres-
sion of NrnB but not the NrnB-DHH mutant. Transformants of strain
UM341 with pBAD18 (vector control), pUM408 (arabinose-inducible
orn), pUM414 (arabinose-inducible nrnB) or pUM443 (arabinose-
inducible NrnB-DHH mutant) were spread on LB plates containing
0.2% arabinose in the absence of anhydrotetracycline (Atc).
5118 Nucleic Acids Research, 2009, Vol. 37,No. 15on nanoRNA 5-mers (50Cy5-CCCCC30) was still detect-
able (Figure 3), but was dramatically reduced with an esti-
mated activity of less than 1% of that of wild-type NrnB.
The activity of the NrnB-DHH mutant on the 24-mer
was not visible by eye and amounted to less than 10%
of that of NrnB (data not shown), which clearly showed
activity on the 24-mer (Figure 4). However, the activity of
NrnB on the 24-mer was considerably less than that on
nanoRNA. The NrnB-catalyzed degradation of 24-mers,
measured as disappearance of substrate, was roughly
estimated at 2pmol/mg/min (1–4). This amounts to three
orders of magnitude lower than its activity on nanoRNA
5-mers, but is 200-fold greater than that of NrnA on
24-mers.
Phylogenetic distribution of NrnB
We searched the databases for homologs of NrnB.
Table S1 lists NrnB orthologs that were deﬁned by
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Figure 2. NrnB-catalyzed degradation of nanoRNA. Shown is the separation of reaction products on 22% PAA gels (A, B, E, F). The reverse
migration can be accounted for by the fact that cyanine dyes have a lower net negative charge than nucleic acids: thus, removing nucleotides will
reduce the charge relative to the mass of the oligonucleotide and cause it to shift up instead of down. Panels (C) and (D) show quantiﬁcations of
reaction products and intermediates of degradation of 50Cy5-CCCCC30 and 50Cy5-AAAAA30, respectively. 50ml reactions contained 0.25mg NrnB
and 6.0mM RNA (50Cy5-CCCCC30 for A and C, 50Cy5-AAAAA30 for B and D,5 0Cy5-CCC30 for E, and 50Cy5-AAA30 for F). The minus indicates
controls lacking enzyme. (C and D) Closed circles: 5-mers, open circles: 4-mers, closed triangles: 3-mers, open triangles: 2-mers, squares: 1-mers. (G)
Comparison of initial rates of degradation of 50Cy5-AAAAA30, 5A; 50Cy5-CCCCC30, 5C; 50Cy5-AAA30, 3A; and 50Cy5-CCC30, 3C. Speciﬁc
activities measured as disappearance of substrate were normalized according to the activity on 50Cy5-AAAAA30, which was set to be 1.
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Figure 3. Activity of NrnB-DHH on nanoRNA (50Cy5-CCCCC30).
Fifty-microliter reactions contained 5mg NrnB-DHH and 6mM RNA
5-mer (50Cy5-CCCCC30).
Nucleic Acids Research, 2009,Vol.37, No. 15 5119fulﬁlling the following criteria:  20% diﬀerence in protein
length, alignment extends over  80% of the protein, and
 40% amino-acid similarity. The 41 sequences fulﬁlling
these criteria (sequences from one particular strain of one
species are counted for one) originated mainly from spe-
cies closely related to B. subtilis. However, orthologs were
also found in e-proteobacteria like Helicobacter sp. and
Campylobacter sp. and in some archaea. We constructed
a phylogenetic tree on http://www.phylogeny.fr using
the 41 sequences deﬁned in Table S1. Figure S1 shows
a simpliﬁed version of this tree that was obtained by
omitting multiple sequences that took an identical posi-
tion in the tree and belonged to the same species.
YhaM activity on nanoRNA and DNA
In our screen for B. subtilis genes that were able to com-
plement E. coli orn
–, we also identiﬁed a clone containing
nt 1068397–1070326 of the B. subtilis genome (pBSL10).
This region contains partial CDSs coding for YhaM, PrsA
and a complete CDS coding for YhaL. YhaL is a gene of
unknown function, implicated in sporulation (21). prsA
codes for a molecular chaperone that is involved in protein
secretion, this CDS was largely deleted in pBSL10. This
plasmid coded only for the C-terminal part of PrsA pro-
tein (one-third of the full length). The CDS coding for
YhaM was incomplete and allowed only for the expression
of an N-terminally modiﬁed protein with the ﬁrst 16
amino-acid residues replaced by a 24 amino-acid peptide
encoded by the vector sequence. Despite that fact, we con-
sidered YhaM as the most likely candidate to be respon-
sible for the complementation of E. coli orn
–,a si ti sa
previously characterized RNase (14,22). We therefore sub-
cloned yhaM under the control of the arabinose-inducible
promoter Para in pBAD18. This plasmid (pUM413),
however, did not allow complementation of orn
–.
We subsequently constructed two additional high copy
number plasmids expressing YhaM. pUM416 expressed
C-terminally his-tagged YhaM under control of the PLac
promoter in pUC18. pFM1 expressed native yhaM under
control of its own promoter in pGEMT-Easy. pFM1 was
the only construct allowing partial complementation of
orn
– (Figure 5). This could suggest that either high expres-
sion levels were necessary for complementation, or that
the his-tag interfered with the activity of YhaM.
Comparing expression levels, we found that indeed the
original library clone that complementated orn
– allowed
very high expression of YhaM, which was easily detectable
on a colloidal coomassie-stained gel. On the contrary,
none of the other YhaM-expressing constructs allowed
protein detection, partially due to presence of other pro-
teins in this gel region. However, using western blot ana-
lysis with Anti-His6 the expression of all his-tagged
proteins was detected (data not shown).
His-tagged YhaM puriﬁed from E. coli carrying
pUM413 was able to degrade nanoRNA in vitro
(Figure 6A). This suggests that the presence of his-tag
does not account for the inability of pUM413 and
pUM416 to complement the orn
– mutation, although we
cannot exclude partial inhibition of YhaM nanoRNase
activity by the his-tag. The pattern of degradation of the
nanoRNA 5-mer (50Cy5-CCCCC30) was similar to that
produced by Orn- or NrnB-catalyzed degradation.
The high expression levels required for complementation
of E. coli orn
–, however, made us consider that nanoRNA
might not be a physiological substrate for YhaM.
orn
vector
yhaM lc
yhaM hc
Figure 5. Lacking or partial complementation of the conditional orn
mutant by expression of YhaM from diﬀerent constructs diﬀering in
copy number. Transformants of strain UM341 with pBAD18 (vector
control), vector; pUM408 (arabinose-inducible orn), orn; pUM413 (ara-
binose-inducible yhaM in pBAD18, a low-copy (lc) number vector),
yhaMlc; or pFM1 (yhaM in pGEMT-Easy, a high-copy (hc) number
vector), yhaMhc were spread on LB plates containing 0.2% arabinose
in the absence of anhydrotetracycline (Atc).
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Figure 4. Activity of NrnB on RNA 24-mers. Reactions containing
50 33P-labeled RNA 24-mers (50CACACACACACACACACACACAC
A30) and 0.5mg NrnB or no enzyme (minus) were incubated at 378C.
M, decade marker; H, alkaline hydrolysis control.
5120 Nucleic Acids Research, 2009, Vol. 37,No. 15We therefore decided to compare the activity of YhaM on
RNA and DNA substrates 5nt in length.
Figure 6 compares YhaM activity on oligo RNA and on
oligo DNA. YhaM degraded the RNA 5-mer at an initial
rate of 0.76pmol/min/mg, while it degraded 5-mer DNA at
a rate of 10.14pmol DNA 5-mer/min/mg enzyme during
the ﬁrst minute of the reaction. Since the DNA monomer
did not enter the gels, it could not be included in the
quantiﬁcation. The values of all other reaction intermedi-
ates, as well as the value for the substrate 5-mer were
therefore overrestimated, as soon as monomer appeared
in the reaction. The turnover rate of the 5-mer DNA after
1min might therefore be slightly underestimated. The
appearance of 2-mer was much more rapid for the DNA
than for RNA substrate, and the degradation of 270pmol
nanoRNA was less complete after 30min by 20mg YhaM,
compared to the degradation of the same quantity of
nanoDNA by 4mg YhaM.
A triple mutant lacking nrnA, nrnB and yhaM is viable
As Orn is essential in E. coli, we wanted to ask if deleting
all sources of nanoRNase activity known to us, i.e. nrnA,
nrnB and yhaM would be lethal in B. subtilis. For this
purpose we constructed an nrnB::Cm
R replacement allele
and an allele carrying nrnA under control of the IPTG-
inducible promoter PSpac. We combined these two alleles
with the yhaM::Phleo
R allele (14). Table 2 shows the
results of growth experiments performed with mutants
containing one or multiple mutant alleles. Growth of the
single mutants in nrnA or nrnB as well as the double
mutant was not aﬀected. Growth of the triple mutant
carrying nrnA under control of PSpac and replacement
alleles for nrnB and yhaM (strain UM629) was only
slightly aﬀected in the absence of IPTG.
We also created triple mutants with three replacement/
insertional alleles. These strains (UM647 and UM651)
were also only marginally aﬀected in growth like the
triple mutant carrying nrnA under the control of PSpac in
the absence of IPTG (Table 2).
RNase J1 is able to degrade nanoRNA
According to in vitro data, the essential enzyme RNase J1
does not produce large quantities of 2- to 5-mers as end
products of RNA 50-to-30 degradation (10). This encour-
aged us to test activity of RNase J1 on nanoRNA. Despite
the fact that our in vitro conditions were not ideal (our
substrate was labeled at the 50 end with Cy-5, which could
potentially interfere with 50–30 directed degradation), the
release of mononucleotides (Figure 7) indicated activity
of RNase J1 on nanoRNA 5-mers (50Cy5-AAAAA30).
Activity on 50Cy5-CCCCC-30 was barely detectable
(Figure 7). Estimations of speciﬁc activities of RNase J1
on 50Cy5-AAAAA30 and 50Cy5-CCCCC-30 revealed a
roughly 10-fold diﬀerence in favor of 50Cy5-AAAAA30
with 0.5pmol/min/mg as compared to 0.03pmol/min/mg,
respectively. An inactive mutant RNAse J1 (H46A)
was included in order to exclude the possibility of con-
taminating activity in the RNAse J1 preparation and
showed no detectable activity on either substrate.
To test whether expression of RNase J1 could comple-
ment E. coli orn
–, we transformed pDG148-rnjA into
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Figure 6. Comparison of YhaM activity on RNA and DNA substrates.
Shown is the separation of reaction products on 22% PAA gels.
50ml reactions contained (A)2 0 mg YhaM and 5.4mM RNA oligo
(50Cy5-CCCCC30)o r( B)4 mg YhaM and 5.4mM DNA oligo (50Cy5-
CCCCC30).
Table 2. Doubling times of mutant strains in nrnA, nrnB and yhaM
Strain Genotype Doubling time (min)
–IPTG +IPTG
B. subtilis 168 Wild type 24
UM516 yhaM::Phleo
R 24
UM545 nrnB::Cm
R 23
UM599 nrnA::Km
R 24
UM638 nrnB::Cm
R, nrnA::Km
R 25
UM629 PSpac::nrnA, nrnB::Cm
R,
yhaM::Phleo
R
(pMAP65 i.e. lac-I
Q)
29 25
UM647 nrnA::Km
R, nrnB::Cm
R,
yhaM::Phleo
R
26
UM651 nrnA::Em
R, nrnB::Cm
R,
yhaM::Phleo
R
27
Nucleic Acids Research, 2009,Vol.37, No. 15 5121UM341. This plasmid carries rnjA coding for RNase J1
under the control of the IPTG-inducible PSpac promoter.
When transformed into the conditional orn mutant,
colony sizes depended strongly on the concentration of
IPTG added to the plates (Table 3). Complementation
seemed to be partial in the absence of IPTG or at very
low concentrations of the inducer (10mM). At higher con-
centrations of IPTG, however, no colonies could be
detected. The absence of growth at high IPTG concentra-
tions may be due to the detrimental eﬀect of RNase J1
overexpression even in Orn
+ conditions, indicated by the
fact that the colony size of transformants spread under
permissive conditions in the presence of  50mM IPTG
was adversely aﬀected (Table 3).
DISCUSSION
The purpose of this study was to search for enzymes that
allow B. subtilis to degrade nanoRNA. We identify here
one new nanoRNase, NrnB (previously YngD) and we
tested nanoRNase activity of two known RNases,
YhaM and RNase J1. All three enzymes are able to
degrade nanoRNA in vitro to various extents. NrnB, how-
ever, is the only one of these three enzymes that allows full
complementation of an E. coli orn mutant when expressed
at low levels. This suggests that nanoRNA might not be
the preferred or physiological substrate for YhaM or
RNase J1.
YhaM
Despite the fact that a genomic library clone (pBSL10)
containing most of the CDS for YhaM was found
among the clones complementing the E. coli orn mutant,
when subcloned, yhaM could only partially comple-
ment this mutant, even when expressed from a high
copy number plasmid. Possible explanations for this
discrepancy that one could consider are: (i) the changed
protein sequence of the protein expressed from pBSL10
(16N-terminal amino acids replaced by 24 amino acids
encoded by the vector) could aﬀect substrate speciﬁcity
of the protein. (ii) Expression of yhaL, another CDS
present in pBSL10, might be necessary for YhaM in vivo
in order to complement the orn mutant. This hypothesis
could not be tested as we were unable to obtain any viable
clones coding for YhaM and YhaL (data not shown). The
few clones that we obtained carried mutations and
formed very small colonies suggesting that expression of
those two genes together might be toxic in E. coli. (iii)
High expression levels of YhaM are necessary for comple-
mentation. We consider the latter explanation the most
likely due to the fact that the library clone allowing com-
plementation indeed showed very high expression levels
of YhaM. All other YhaM constructs did not allow detec-
tion of the expressed protein on a coomassie-stained
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Figure 7. Degradation of nanoRNA 5-mers by RNase J1. Thirty-
microliter reactions contained 3mg RNase J1 or 5mg RNase J1
mutant protein (RNase J1 H46A, H46A mut) and 5mM RNA oligo
(50Cy5-AAAAA30, Figure 7A;o r5 0Cy5-CCCCC30, Figure 7B). The
minus indicates controls lacking enzyme.
Table 3. Growth of UM341 (E. coli orn
–) carrying a vector control or expressing RNase J1 in the presence of varying concentrations of IPTG
Plasmid +Atc IPTG in mM  Atc IPTG in mM
0 10 50 100 200 0 10 50 100 200
pBAD18 (vector) ++++ ++++ ++++ ++++ ++++ + + + + +
pDG148-rnjA (RNase J1) ++++ ++++ +++ ++ – ++ ++ – – –
pUM408 (Orn) ++++
a ++++
a
Colony sizes: ++++, wild type; +++, smaller; ++, very small; +, tiny; –, no growth, Atc: anhydrotetracycline.
aIn the presence of 0.02% arabinose.
5122 Nucleic Acids Research, 2009, Vol. 37,No. 15protein gel due to its overlap with a strong band on the
gel. The expression of his-tagged YhaM constructs that
did not allow complementation was however detectable
using Anti-His6 antibodies. Importantly, the expression
of other nanoRNases, NrnB and NrnA, in the absence
of inducer was not detectable by Anti-His6 antibodies
and yet allowed complementation. However, a note of
caution is warranted due to the fact that direct compari-
son between protein levels of NrnB, NrnA and YhaM
might not be possible as the his-tag of diﬀerent proteins
could react diﬀerently with the Anti-His6 antibody due
to diﬀerent accessibility of the epitope. Consequently we
are left with some uncertainty concerning the amount
of YhaM present in constructs that did not allow comple-
mentation and cannot completely exclude that nanoRNA
is a physiological substrate for YhaM.
The strong preference of DNA over RNA 5-mers that
we observed in vitro could be another argument against
nanoRNase being the main activity of YhaM in bacterial
cells. In addition, this preference for DNA could point to
a potential role of YhaM in DNA metabolism. yhaM is
located in an operon containing yhaO, yhaN and yhaM
that was identiﬁed as a part of the SOS LexA regulon in
B. subtilis (23). The LexA-binding site is located upstream
of the promoter region of the operon preceding yhaO. The
corresponding sequence (aGAACgTgcaTTCG) diﬀers in
ﬁve positions from the consensus sequence. Global tran-
scriptome analysis by microarrays shows that YhaO and
YhaM are induced in a RecA-dependent manner when the
SOS response is induced by mitomycin C or UV radiation
(23). Although the functions of YhaO and YhaN are
unknown, YhaO is annotated as a member of the SbcD
protein family containing metallophosphoesterases
involved in DNA repair, recombination and replication
(24) and YhaN contains a domain with homology to
this protein family. Thus, both YhaO and YhaN likely
play a role in DNA metabolism, and our enzymatic
assays suggest that YhaM might as well. Furthermore,
all three proteins were linked in an interaction network
that connects DNA repair, recombination and replication.
Direct interaction between YhaM and DnaC, as well as
between DnaG and YhaN was shown by yeast two
hybrids screens (25). YhaO was linked indirectly through
interaction with YhaN (25). Altogether, this demonstrates
that the role of YhaM in nucleic acid metabolism still
needs to be clariﬁed.
RNase J1
Despite the in vitro activity of RNase J1 on nanoRNA,
it is diﬃcult to ascertain whether or not nanoRNA is a
physiological substrate of this enzyme. This is because
expression of RNase J1 seems to be detrimental to
growth in E. coli, at least in the orn mutant strain we
used. According to in vitro evidence (10,26), it is likely
that RNase J1 degrades RNA completely and does not
leave 2- to 5-mers in vivo. As this essential enzyme does
have many other substrates (27), nanoRNA may not be a
preferred substrate and therefore despite the ability of
RNase J1 to ﬁnish degradation once started on a longer
substrate, it might not pick up 2- to 5-mers that arise from
incomplete degradation catalyzed by other enzymes.
NrnB
NrnB degrades nanoRNA 5-mers in vitro in a manganese-
or cobalt-dependent 30–50 directed reaction and can com-
plement an E. coli orn
– mutant when expressed at low
levels. Both in vitro and in vivo evidence presented here
allow annotation of NrnB as a nanoRNase. The large
activity diﬀerence in favor of 5-mer as compared to
24-mer substrate implies that nanoRNA is a preferred
substrate of NrnB. After NrnA, NrnB is the second pro-
tein in B. subtilis that we have identiﬁed as a nanoRNase.
We therefore proposed to rename YtqI and YngD as
NrnA and NrnB, respectively.
Both proteins are members of the DHH/DHHA1 pro-
tein family of phosphoesterases, it is therefore likely that
one can ﬁnd other nanoRNases among the DHH proteins
of unknown function. As in the case of NrnA and NrnB,
these proteins may diﬀer in their substrate speciﬁcity: the
substrate speciﬁcity of NrnA is not restricted to nanoRNA
but extends to pAp. We show here that this is not the case
for NrnB. Although NrnA has a strong preference for 3-
mers in vitro, NrnB does not show such a preference and
has in fact lower activity on 3-mers than on 5-mers. Thus,
the two nanoRNases present in B. subtilis have diﬀerent
but overlapping substrate speciﬁcities, which could add
some functional redundancy and/or specialization in this
organism. Despite the fact that the speciﬁc activity of
NrnA on 5-mer C’s is considerably lower in vitro than
that of NrnB (0.2pmol/mg/min versus 1nmol/mg/min,
respectively) [data extracted from ref. (6)], both enzymes
are able to complement the E. coli orn mutant when
expressed at low levels. Due to the preference of NrnA
for 3-mers, the diﬀerence between the speciﬁc activity of
NrnA and NrnB is much smaller when considering activ-
ities on 3-mers (<6-fold). Nevertheless, even with 3-mers,
NrnB is more active than NrnA. However, it is possible
that conditions for activity assays of NrnA were not opti-
mal and therefore, direct comparison of speciﬁc activities
of the two enzymes should not be over interpreted. Also,
the fact that many bacterial species that do not carry Orn,
have only NrnA and not NrnB supports the importance of
NrnA as a nanoRNase under physiological conditions.
NrnB is present in a smaller number of genomes as
compared to NrnA, and several of those species are closely
related to B. subtilis. However, we also found NrnB ortho-
logs in e-proteobacteria, namely Helicobacter sp. and
Campylobacter sp. and in some Archaea. Intriguingly,
e-proteobacteria possesses neither Orn- nor NrnA-ortho-
logs. NrnB might therefore play a more important role
in the degradation of nanoRNA in these organisms,
although the simultaneous presence of RNase J1 homo-
logs in these species might contribute as well.
Simultaneous deletion of nrnA, nrnB and yhaM in
B. subtilis has a minor eﬀect, if any, on growth in complex
medium. This result could be interpreted in two ways:
(i) RNase J1/J2 can take over this essential function
in the absence of these three genes. This hypothesis
cannot be tested easily due to essentiality of RNase J1
Nucleic Acids Research, 2009,Vol.37, No. 15 5123itself. (ii) Yet another protein exists in B. subtilis that has
nanoRNase activity. We cannot exclude this possibility, as
our genomic library screen for the orn
– complementing
genes was not saturated. Candidates might be among the
DHH proteins of unknown function in Bacillus: YorK
and YybT, for example.
With the identiﬁcation of NrnA and NrnB, however,
our work demonstrates that the degradation of
nanoRNA catalyzed by a single protein Orn in E. coli is
performed by redundant proteins in B. subtilis. This is a
remarkable example of xenologous gene replacement (28)
in the case of coding for ubiquitous functions.
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